Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients ; volume:20 ; number:1 ; day:13 ; month:5 ; year:2022 ; pages:1-16 ; date:12.2022
Journal of translational medicine ; 20, Heft 1 (13.5.2022), 1-16, 12.2022
- Urheber
-
Liao, Hao
Zhang, Jiayang
Zheng, Tiantian
Liu, Xiaoran
Zhong, Jianxin
Shao, Bin
Dong, Xiaoxi
Wang, Xiaohong
Du, Pan
King, Bonnie L.
Jia, Shidong
Yu, Jianjun
Li, Huiping
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-022-03421-8
- URN
-
urn:nbn:de:101:1-2022071821190256185770
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liao, Hao
- Zhang, Jiayang
- Zheng, Tiantian
- Liu, Xiaoran
- Zhong, Jianxin
- Shao, Bin
- Dong, Xiaoxi
- Wang, Xiaohong
- Du, Pan
- King, Bonnie L.
- Jia, Shidong
- Yu, Jianjun
- Li, Huiping
- SpringerLink (Online service)
Ähnliche Objekte (12)
Biomarkers in cancer/Circulating tumour markers
The circulating miRNAs as diagnostic and prognostic markers
Circulating tumor cells as a diagnostic and prognostic marker for hepatocellular carcinoma
Suitability of circulating microRNAs as potential prognostic markers in colorectal cancer
Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
Investigation of circulating microRNAs and circulating DNA as diagnostic and prognostic markers in metastatic breast cancer
Circulating Tumour DNA in Melanoma—Clinic Ready?
Circulating tumour mutation detection in triple-negative breast cancer as an adjunct to tissue response assessment
Enolase Isoenzymes as Tumour Markers
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Ex vivo expansion of circulating tumour cells (CTCs)
Biomarkers in cancer/Circulating tumour markers
The circulating miRNAs as diagnostic and prognostic markers
Circulating tumor cells as a diagnostic and prognostic marker for hepatocellular carcinoma
Suitability of circulating microRNAs as potential prognostic markers in colorectal cancer
Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
Investigation of circulating microRNAs and circulating DNA as diagnostic and prognostic markers in metastatic breast cancer
Circulating Tumour DNA in Melanoma—Clinic Ready?
Circulating tumour mutation detection in triple-negative breast cancer as an adjunct to tissue response assessment
Enolase Isoenzymes as Tumour Markers
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Ex vivo expansion of circulating tumour cells (CTCs)
Biomarkers in cancer/Circulating tumour markers
The circulating miRNAs as diagnostic and prognostic markers
Circulating tumor cells as a diagnostic and prognostic marker for hepatocellular carcinoma
Suitability of circulating microRNAs as potential prognostic markers in colorectal cancer
Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
Investigation of circulating microRNAs and circulating DNA as diagnostic and prognostic markers in metastatic breast cancer
Circulating Tumour DNA in Melanoma—Clinic Ready?
Circulating tumour mutation detection in triple-negative breast cancer as an adjunct to tissue response assessment
Enolase Isoenzymes as Tumour Markers
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?